NIDEA Papers
Permanent URI for this collection
NIDEA undertakes research at the interface of population and economics to help inform choices and responses to the demographic, social and economic interactions that are shaping New Zealand's future.
Recent Submissions
Item Te Pūtahitanga: A Tiriti-led science-policy approach for Aotearoa New Zealand(Report, Ngā Pae o te Māramatanga, 2021-04-28) Kukutai, Tahu; McIntosh, T; Durie, M; Boulton, A; Foster, M; Hutchings, J; Mark-Shadbolt, M; Moewaka Barnes, H; Moko-Mead, TT; Paine, S-J; Pitama, S; Ruru, JThis paper examines the interface between science and policymaking and calls for a policy approach that is enabled by, and responsive to, Te Tiriti o Waitangi and Mātauranga Māori. For a science sector to have its greatest reach and impact for all citizens, it must demonstrate relevance, accessibility and inclusion. In Aotearoa, there has been concern about the exclusion of Māori and Pacific expertise from science advice and key decision-making roles. Te Tiriti offers a powerful framework for connecting systems and communities of knowledge in ways that are mutually beneficial and future focused.Item Prevalence of gestational diabetes in the Waikato region of New Zealand(Journal Article, Wiley, 2022) Chepulis, Lynne Merran; Morison, Brittany; Lawrenson, Ross; Paul, RyanGestational diabetes mellitus (GDM) during pregnancy is associated with health complications for both mother and infant, but patient numbers in the Waikato District Health Board region of New Zealand have not been well characterised. This study reviewed the full 2018 cohort of Waikato District Health Board hospital births (n = 4970) to report on GDM prevalence by ethnicity and age. The overall prevalence of GDM was 5.7% and is more likely to affect Asian, Pacific and Māori women as well as those of advanced maternal age.Item The COVID-19 domestic vaccine pass: Implications for Māori(Report, National Institute of Demographic and Economic Analysis, 2021-11-30) Kukutai, Tahu; Clark, Vanessa; Mika, Jason; Muru-Lanning, Marama; Pouwhare, Robert; Sterling, Rogena; Teague, Vanessa; Watts, David; Cassim, ShemanaThe New Zealand government has introduced a COVID-19 domestic vaccine pass to be used in conjunction with the COVID-19 Protection Framework. The Framework is likely to be activated soon after Cabinet meets on 29 November 2021. The pass will be necessary to access places and events that require proof of vaccination under the Framework. This brief does not argue for or against the introduction of a domestic vaccine pass, but rather discusses key issues that it raises for Māori, and suggests actions to address them. We see four key issues: • the lack of Māori involvement, as a Tiriti partner, on either the design or implementation of the COVID-19 domestic vaccine pass; • disproportionate restriction on Māori mobility due to lower Māori vaccination rates; • privacy and data security concerns; • uneven implementation that could increase discrimination against Māori and other groups considered to pose a risk to others’ safety. To respond to these issues we recommend that the implementation of the pass be designed in partnership with Māori and comply with Māori data sovereignty requirements. As Tiriti partners, Māori should expect that the pass will keep their communities safe, while providing opportunities to enact manaakitanga in the matrix of care, and the mana to manage their own affairs.Item Initial report of the 2018 Census external data quality panel(Report, Stats NZ, 2019) Bedford, Richard; Reid, Alison; Milne, Barry; Cormack, Donna; Cope, Ian; Cook, Len; Kukutai, Tahu; Lumley, ThomasOne in six New Zealand residents did not complete a questionnaire for the 2018 New Zealand Census of Population and Dwellings. This was largely due to operational failures that made it difficult for a significant number of individuals and households to access census questionnaires, and to fulfill their statutory duty to participate.Item Barriers to diabetes self-management in a subset of New Zealand adults with Type 2 diabetes and poor glycaemic control(Journal Article, Hindawi Ltd, 2021) Chepulis, Lynne Merran; Morison, Brittany; Cassim, Shemana; Norman, Kimberley; Keenan, Rawiri; Paul, Ryan G.; Lawrenson, RossBackground. Despite the fact that there is an increasingly effective armoury of medications to treat diabetes, many people continue to have substantially elevated blood glucose levels. The purpose of this study was to explore what the barriers to diabetes management are in a cohort of people with diabetes and poor glycaemic control. Methods. Qualitative semistructured interviews were carried out with 10 people with diabetes who had known diabetes and a recent HbA1c of >11.3% (100 mmol/mol) to explore their experiences of barriers to diabetes self-management and glycaemic control. Results. Barriers to diabetes management were based around two key themes: biopsychosocial factors and knowledge about diabetes. Specifically, financial concerns, social stigma, medication side effects, and cognitive impairment due to hyperglycaemia were commonly reported as barriers to medication use. Other barriers included a lack of knowledge about their own condition, poor relationships with healthcare professionals, and a lack of relevant resources to support diet and weight loss. Conclusion. People with diabetes with poor glycaemic control experience many of the same barriers as those reported elsewhere, but also experience issues specifically related to their severe hyperglycaemia. Management of diabetes could be improved via the increased use of patient education and availability of locally relevant resources.